razoxane has been researched along with dactinomycin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olweny, CL | 1 |
| Vogel, CL | 1 |
| Bayley, AC | 1 |
| Azuma, Y; Kizaki, H; Onishi, Y | 1 |
| Chen, S; Garami, M; Gardner, DG | 1 |
1 review(s) available for razoxane and dactinomycin
| Article | Year |
|---|---|
Management of Kaposi's sarcoma. Chemotherapy I.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Carmustine; Dactinomycin; Humans; Immunosuppressive Agents; Prednisone; Razoxane; Sarcoma, Kaposi; Vinca Alkaloids | 1981 |
1 trial(s) available for razoxane and dactinomycin
| Article | Year |
|---|---|
Management of Kaposi's sarcoma. Chemotherapy II.
Topics: Bleomycin; Carmustine; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Humans; Razoxane; Sarcoma, Kaposi; Uganda; Vincristine | 1981 |
3 other study(ies) available for razoxane and dactinomycin
| Article | Year |
|---|---|
Role of surgery in the management of Kaposi's sarcoma in Lusaka Zambia.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Arm; Arthrodesis; Dactinomycin; Electrocoagulation; Humans; Leg; Male; Middle Aged; Razoxane; Sarcoma, Kaposi; Vincristine; Zambia | 1981 |
bis(2,6-dioxopiperaxine) derivatives, topoisomerase II inhibitors which do not form a DNA cleavable complex, induce thymocyte apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Cycloheximide; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Nucleic Acid Conformation; Piperazines; Razoxane; Thymus Gland; Topoisomerase I Inhibitors | 1994 |
Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Survival; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression; Heart Atria; Natriuretic Peptide, Brain; Probucol; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Rats; Razoxane; RNA, Messenger; Transfection | 1999 |